Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.

[1]  H. Morreau,et al.  Increased frequency of 20q gain and copy‐neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas , 2012, International journal of cancer.

[2]  Wei Huang,et al.  Insulin‐like growth factor‐2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer , 2011, The Prostate.

[3]  J. Berg,et al.  Imprinted Genes That Regulate Early Mammalian Growth Are Coexpressed in Somatic Stem Cells , 2011, PloS one.

[4]  G. Rosner,et al.  Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy , 2011, Cancer.

[5]  E. Ozkan.  Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review , 2011, Molecular and Cellular Endocrinology.

[6]  B. Cairns,et al.  Genome-wide analysis identifies changes in histone retention and epigenetic modifications at developmental and imprinted gene loci in the sperm of infertile men. , 2011, Human reproduction.

[7]  E. Hatzimichael,et al.  MEG3 imprinted gene contribution in tumorigenesis , 2011, International journal of cancer.

[8]  E. Kavanagh,et al.  The hallmarks of CDKN1C (p57, KIP2) in cancer. , 2011, Biochimica et biophysica acta.

[9]  A. Theocharis,et al.  Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas , 2011, BMC Cancer.

[10]  Shengyue Wang,et al.  Digital karyotyping reveals probable target genes at 7q21.3 locus in hepatocellular carcinoma , 2011, BMC Medical Genomics.

[11]  Jeannie T. Lee,et al.  YY1 Tethers Xist RNA to the Inactive X Nucleation Center , 2011, Cell.

[12]  Hongyue Dai,et al.  DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor Survival , 2011, The Journal of Biological Chemistry.

[13]  L. Schaefer.  Small leucine-rich proteoglycans in kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[14]  D. Sassoon,et al.  PW1 gene/paternally expressed gene 3 (PW1/Peg3) identifies multiple adult stem and progenitor cell populations , 2011, Proceedings of the National Academy of Sciences.

[15]  L. Tran,et al.  Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. , 2011, Cancer cell.

[16]  K. Jöckel,et al.  Lack of Association of the Genotype in the GNAS Fok I Polymorphism and Prostate Cancer , 2011, Urologia Internationalis.

[17]  Sarat Chandarlapaty,et al.  Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. , 2011, Cancer cell.

[18]  Xunxian Liu,et al.  Androgen‐induced PSA expression requires not only activation of AR but also endogenous IGF‐I or IGF‐I/PI3K/Akt signaling in human prostate cancer epithelial cells , 2011, The Prostate.

[19]  S. Brewster,et al.  Serial analysis of resected prostate cancer suggests up‐regulation of type 1 IGF receptor with disease progression , 2011, BJU international.

[20]  A. Agarwal,et al.  Epigenetics, spermatogenesis and male infertility. , 2011, Mutation research.

[21]  F. Baas,et al.  SGCE isoform characterization and expression in human brain: implications for myoclonus–dystonia pathogenesis? , 2011, European Journal of Human Genetics.

[22]  M. Ittmann,et al.  INPP4B: the New Kid on the PI3K Block , 2011, Oncotarget.

[23]  M. Shen,et al.  Revisiting the concept of cancer stem cells in prostate cancer , 2011, Oncogene.

[24]  A. Chase,et al.  Aberrations of EZH2 in Cancer , 2011, Clinical Cancer Research.

[25]  M. Lacher,et al.  Altered expression of imprinted genes in Wilms tumors. , 2011, Oncology reports.

[26]  T. Rauch,et al.  Chromosome-Wide Analysis of Parental Allele-Specific Chromatin and DNA Methylation , 2011, Molecular and Cellular Biology.

[27]  M. Bastepe,et al.  Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone. , 2011, Bone.

[28]  G. Christofori.  Metastatic colon cancer cells negotiate the intravasation Notch. , 2011, Cancer cell.

[29]  Leif E. Peterson,et al.  Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer. , 2011, Cancer research.

[30]  K. Fujieda,et al.  Partial paternal uniparental disomy of chromosome 6 in monozygotic twins with transient neonatal diabetes mellitus and macroglossia , 2010, Clinical genetics.

[31]  D. Hober,et al.  Viral induction of Zac1b through TLR3- and IRF3-dependent pathways. , 2010, Molecular immunology.

[32]  Jong Y. Park.  Promoter hypermethylation in prostate cancer. , 2010, Cancer control : journal of the Moffitt Cancer Center.

[33]  B. Cairns,et al.  Alterations in sperm DNA methylation patterns at imprinted loci in two classes of infertility. , 2010, Fertility and sterility.

[34]  M. Shen,et al.  Molecular genetics of prostate cancer: new prospects for old challenges. , 2010, Genes & development.

[35]  A. Lania,et al.  GNAS imprinting and pituitary tumors , 2010, Molecular and Cellular Endocrinology.

[36]  G. Kelsey.  Imprinting on chromosome 20: Tissue‐specific imprinting and imprinting mutations in the GNAS locus , 2010, American journal of medical genetics. Part C, Seminars in medical genetics.

[37]  R. Bronson,et al.  Activation of paternally expressed genes and perinatal death caused by deletion of the Gtl2 gene , 2010, Development.

[38]  David P. Davis,et al.  Diverse somatic mutation patterns and pathway alterations in human cancers. , 2010, Nature.

[39]  Marius Wernig,et al.  An imprinted signature helps isolate ESC-equivalent iPSCs , 2010, Cell Research.

[40]  A. Offiah,et al.  Segmental paternal uniparental disomy (patUPD) of 14q32 with abnormal methylation elicits the characteristic features of complete patUPD14 , 2010, American journal of medical genetics. Part A.

[41]  K. Nishio,et al.  Amplification of GNAS may be an independent, qualitative, and reproducible biomarker to predict progression-free survival in epithelial ovarian cancer. , 2010, Gynecologic oncology.

[42]  H. Tsukamoto,et al.  The Necdin-Wnt Pathway Causes Epigenetic Peroxisome Proliferator-activated Receptor γ Repression in Hepatic Stellate Cells* , 2010, The Journal of Biological Chemistry.

[43]  C. Sander,et al.  Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.

[44]  A. Green,et al.  The IG-DMR and the MEG3-DMR at Human Chromosome 14q32.2: Hierarchical Interaction and Distinct Functional Properties as Imprinting Control Centers , 2010, PLoS genetics.

[45]  Zhaohui S. Qin,et al.  An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. , 2010, Cancer cell.

[46]  A. Malek,et al.  ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer , 2010, PloS one.

[47]  Eduardo Diaz-Rubio,et al.  MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway. , 2010, International journal of oncology.

[48]  R. McIntyre,et al.  The activating mutation R201C in GNAS promotes intestinal tumourigenesis in ApcMin/+ mice via activation of Wnt and ERK1/2 MAPK pathways , 2010, Oncogene.

[49]  M. Taniwaki,et al.  PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma. , 2010, Cancer genetics and cytogenetics.

[50]  Wei Li,et al.  Activation of the Imprinted Dlk1-Dio3 Region Correlates with Pluripotency Levels of Mouse Stem Cells , 2010, The Journal of Biological Chemistry.

[51]  A. Loriot,et al.  DNA hypomethylation in cancer: Epigenetic scars of a neoplastic journey , 2010, Epigenetics.

[52]  I. Clay,et al.  The transcriptional interactome: gene expression in 3D. , 2010, Current opinion in genetics & development.

[53]  A. Hochberg,et al.  The oncofetal H19 RNA connection: hypoxia, p53 and cancer. , 2010, Biochimica et biophysica acta.

[54]  W. Schulz,et al.  Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma. , 2010, Cancer genomics & proteomics.

[55]  A. Hoffman,et al.  Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells. , 2010, Human molecular genetics.

[56]  Su Qu,et al.  PI3K-AKT-mTOR Pathway is Dominant over Androgen Receptor Signaling in Prostate Cancer Cells , 2010, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[57]  Yihong Ma,et al.  CDKN1C Negatively Regulates RNA Polymerase II C-terminal Domain Phosphorylation in an E2F1-dependent Manner* , 2010, The Journal of Biological Chemistry.

[58]  Baocun Sun,et al.  Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer , 2010, Journal of experimental & clinical cancer research : CR.

[59]  S. Llanos,et al.  HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions , 2010, Oncogene.

[60]  Kirsten R. McEwen,et al.  Distinguishing epigenetic marks of developmental and imprinting regulation , 2010, Epigenetics & Chromatin.

[61]  M. Hafner,et al.  Genetic and Molecular Analyses of PEG10 Reveal New Aspects of Genomic Organization, Transcription and Translation , 2010, PloS one.

[62]  Mark D. Johnson,et al.  The Imprinted Gene PEG3 Inhibits Wnt Signaling and Regulates Glioma Growth* , 2010, The Journal of Biological Chemistry.

[63]  A. Hölscher,et al.  Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancer. , 2009, World journal of gastroenterology.

[64]  J. Epstein,et al.  Inpp5f Is a Polyphosphoinositide Phosphatase That Regulates Cardiac Hypertrophic Responsiveness , 2009, Circulation research.

[65]  V. Gorgoulis,et al.  p57KIP2: “Kip”ing the Cell under Control , 2009, Molecular Cancer Research.

[66]  K. Sandhu,et al.  Nonallelic transvection of multiple imprinted loci is organized by the H19 imprinting control region during germline development. , 2009, Genes & development.

[67]  S. Nishikawa,et al.  Necdin restricts proliferation of hematopoietic stem cells during hematopoietic regeneration. , 2009, Blood.

[68]  M. Knowles,et al.  Necdin: A multi functional protein with potential tumor suppressor role? , 2009, Molecular carcinogenesis.

[69]  Kristian Helin,et al.  Polycomb group proteins: navigators of lineage pathways led astray in cancer , 2009, Nature Reviews Cancer.

[70]  Laurent Journot,et al.  H19 acts as a trans regulator of the imprinted gene network controlling growth in mice , 2009, Development.

[71]  J. O'flaherty,et al.  Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways. , 2009, Neoplasia.

[72]  R. Feil,et al.  Chromatin mechanisms in genomic imprinting , 2009, Mammalian Genome.

[73]  K. Hata,et al.  Histone methylation is mechanistically linked to DNA methylation at imprinting control regions in mammals. , 2009, Human molecular genetics.

[74]  L. Nonn,et al.  Evidence for field cancerization of the prostate , 2009, The Prostate.

[75]  F. E. Bertrand,et al.  Notch‐1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression , 2009, Journal of cellular biochemistry.

[76]  Johann S de Bono,et al.  Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer , 2009, Clinical Cancer Research.

[77]  Joomyeong Kim,et al.  YY1's role in DNA methylation of Peg3 and Xist , 2009, Nucleic acids research.

[78]  A. Paradowska,et al.  Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia. , 2009, International journal of oncology.

[79]  A. D. De Marzo,et al.  Epigenetic alterations in human prostate cancers. , 2009, Endocrinology.

[80]  W. Schulz,et al.  Epigenetic mechanisms in the biology of prostate cancer. , 2009, Seminars in cancer biology.

[81]  J. Herman,et al.  Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. , 2009, Cancer research.

[82]  I. Temple,et al.  Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith–Wiedemann syndrome , 2009, European Journal of Human Genetics.

[83]  L. Miller,et al.  CDKN1C (p57KIP2) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells , 2009, PloS one.

[84]  G. Kristiansen,et al.  DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy. , 2009, The Journal of urology.

[85]  M. Oshimura,et al.  Aberrant promoter methylation and expression of the imprinted PEG3 gene in glioma , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[86]  M. Hoque.  DNA methylation changes in prostate cancer: current developments and future clinical implementation , 2009, Expert review of molecular diagnostics.

[87]  T. Eggermann.  Epigenetic regulation of growth: lessons from Silver-Russell syndrome. , 2009, Endocrine development.

[88]  J. Biegel,et al.  Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors , 2009, PloS one.

[89]  D. Richardson,et al.  The TGF-beta, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer. , 2009, The Biochemical journal.

[90]  Katalin Ajtai,et al.  PDLIM4, An Actin Binding Protein, Suppresses Prostate Cancer Cell Growth , 2009, Cancer investigation.

[91]  R. Feil,et al.  Perturbation of genomic imprinting in oligozoospermia , 2009, Epigenetics.

[92]  S. Varambally,et al.  Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer , 2008, Science.

[93]  Linda Jansson,et al.  Delta-like 1 (Dlk-1), a novel marker of prostate basal and candidate epithelial stem cells, is downregulated by notch signalling in intermediate/transit amplifying cells of the human prostate. , 2008, European urology.

[94]  Y. Nakatani,et al.  Molecular analysis of multifocal prostate cancer by comparative genomic hybridization , 2008, The Prostate.

[95]  C. Cooper,et al.  Concepts of epigenetics in prostate cancer development , 2008, British Journal of Cancer.

[96]  E. Bernstein,et al.  Partners in imprinting: noncoding RNA and polycomb group proteins. , 2008, Developmental cell.

[97]  Jennifer A. Erwin,et al.  Polycomb Proteins Targeted by a Short Repeat RNA to the Mouse X Chromosome , 2008, Science.

[98]  J. Peters,et al.  Imprinted noncoding RNAs , 2008, Mammalian Genome.

[99]  P. Abel,et al.  Predictive value of PTEN and AR coexpression of sustained responsiveness to hormonal therapy in prostate cancer--a pilot study. , 2008, Neoplasia.

[100]  K. Yoshikawa,et al.  Necdin Regulates p53 Acetylation via Sirtuin1 to Modulate DNA Damage Response in Cortical Neurons , 2008, The Journal of Neuroscience.

[101]  R. Weindruch,et al.  Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate. , 2008, Cancer Research.

[102]  S. Scherer,et al.  Comparative analysis of human chromosome 7q21 and mouse proximal chromosome 6 reveals a placental-specific imprinted gene, TFPI2/Tfpi2, which requires EHMT2 and EED for allelic-silencing. , 2008, Genome research.

[103]  D. Spengler,et al.  A New Coactivator Function for Zac1's C2H2 Zinc Finger DNA-Binding Domain in Selectively Controlling PCAF Activity , 2008, Molecular and Cellular Biology.

[104]  Shih-Ming Huang,et al.  Modulation of the Cyclin-Dependent Kinase Inhibitor p21WAF1/Cip1 Gene by Zac1 through the Antagonistic Regulators p53 and Histone Deacetylase 1 in HeLa Cells , 2008, Molecular Cancer Research.

[105]  Zhen Lu,et al.  Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down‐regulated in human ovarian cancers by loss of heterozygosity and promoter methylation , 2008, Cancer.

[106]  Xunxian Liu,et al.  Lycopene inhibits IGF-I signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-I production in co-cultured reactive stromal cells. , 2008, Carcinogenesis.

[107]  P. D'Amore,et al.  IGF2: epigenetic regulation and role in development and disease. , 2008, Cytokine & growth factor reviews.

[108]  Yoko Ito,et al.  Distinct Methylation Changes at the IGF2-H19 Locus in Congenital Growth Disorders and Cancer , 2008, PloS one.

[109]  T. Tammela,et al.  EZH2, Ki‐67 and MCM7 are prognostic markers in prostatectomy treated patients , 2008, International journal of cancer.

[110]  M. Sousa,et al.  Abnormal methylation of imprinted genes in human sperm is associated with oligozoospermia. , 2008, Molecular human reproduction.

[111]  G. Kelsey,et al.  Physiological functions of the imprinted Gnas locus and its protein variants Galpha(s) and XLalpha(s) in human and mouse. , 2008, The Journal of endocrinology.

[112]  A. Feinberg,et al.  Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk , 2007, Proceedings of the National Academy of Sciences.

[113]  C. Chen,et al.  JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer , 2007, Proceedings of the National Academy of Sciences.

[114]  A. Karsan,et al.  Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin , 2007, The Journal of experimental medicine.

[115]  D. Ghosh,et al.  A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. , 2007, Cancer research.

[116]  A. Look,et al.  NOTCH and PI3K-AKT pathways intertwined. , 2007, Cancer cell.

[117]  N. Yaegashi,et al.  Aberrant DNA methylation of imprinted loci in sperm from oligospermic patients. , 2007, Human molecular genetics.

[118]  H. Döhner,et al.  Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high‐risk B‐cell chronic lymphocytic leukemia , 2007, International journal of cancer.

[119]  William Davies,et al.  Genomic imprinting effects on brain development and function , 2007, Nature Reviews Neuroscience.

[120]  A. Hochberg,et al.  The H19 Non-Coding RNA Is Essential for Human Tumor Growth , 2007, PloS one.

[121]  W. Schulz,et al.  Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer , 2007, Cancer biology & therapy.

[122]  Z. Qiuping,et al.  Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells , 2007, Oncogene.

[123]  F. Radtke,et al.  Notch and cancer: a double-edged sword , 2007, Cellular and Molecular Life Sciences.

[124]  C. Allis,et al.  DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA , 2007, Nature.

[125]  F. Pauler,et al.  Active and repressive chromatin are interspersed without spreading in an imprinted gene cluster in the mammalian genome. , 2007, Molecular cell.

[126]  F. Pauler,et al.  Silencing by imprinted noncoding RNAs: is transcription the answer? , 2007, Trends in genetics : TIG.

[127]  M. Surani,et al.  Cdkn1c (p57Kip2) is the major regulator of embryonic growth within its imprinted domain on mouse distal chromosome 7 , 2007, BMC Developmental Biology.

[128]  Victoria Bolós,et al.  Notch signaling in development and cancer. , 2007, Endocrine reviews.

[129]  Y. Kohara,et al.  Retrotransposon Silencing by DNA Methylation Can Drive Mammalian Genomic Imprinting , 2007, PLoS genetics.

[130]  A. Fukamizu,et al.  Insulin-like Growth Factor 1/Insulin Signaling Activates Androgen Signaling through Direct Interactions of Foxo1 with Androgen Receptor* , 2007, Journal of Biological Chemistry.

[131]  H. Cui,et al.  Loss of Imprinting of IGF2 as an Epigenetic Marker for the Risk of Human Cancer , 2007, Disease markers.

[132]  R. Feil,et al.  Differential histone modifications mark mouse imprinting control regions during spermatogenesis , 2007, The EMBO journal.

[133]  T. Jenuwein,et al.  Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression , 2007, Nature Cell Biology.

[134]  A. Ferguson-Smith,et al.  Genomic imprinting, growth control and the allocation of nutritional resources: consequences for postnatal life. , 2007, Current opinion in endocrinology, diabetes, and obesity.

[135]  Zohar Yakhini,et al.  Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.

[136]  P. Jelinic,et al.  Loss of imprinting and cancer , 2007, The Journal of pathology.

[137]  T. Barz,et al.  Peroxisome proliferator-activated receptor gamma is a Zac target gene mediating Zac antiproliferation. , 2006, Cancer research.

[138]  R. Schüle,et al.  Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. , 2006, Cancer research.

[139]  K. Sandhu,et al.  Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions , 2006, Nature Genetics.

[140]  Dany Severac,et al.  Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. , 2006, Developmental cell.

[141]  S. Terry,et al.  Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer , 2006, Journal of cellular biochemistry.

[142]  R. Schüle,et al.  Histone demethylation and androgen-dependent transcription. , 2006, Current opinion in genetics & development.

[143]  P. Nelson,et al.  Interaction of IGF signaling and the androgen receptor in prostate cancer progression , 2006, Journal of cellular biochemistry.

[144]  E. Heard,et al.  A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced. , 2006, Genes & development.

[145]  Juri Rappsilber,et al.  The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3 , 2006, Nature.

[146]  N. Kaminski,et al.  Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney. , 2006, Cancer research.

[147]  S. Terry,et al.  Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells , 2006, Oncogene.

[148]  A. Murrell.  Genomic Imprinting and Cancer: From Primordial Germ Cells to Somatic Cells , 2006, TheScientificWorldJournal.

[149]  Takaaki Kuwajima,et al.  Necdin Promotes GABAergic Neuron Differentiation in Cooperation with Dlx Homeodomain Proteins , 2006, The Journal of Neuroscience.

[150]  K. McFann,et al.  DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells. , 2006, American journal of physiology. Endocrinology and metabolism.

[151]  A. Wagschal,et al.  Epigenetic deregulation of imprinting in congenital diseases of aberrant growth. , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[152]  James A. Cuff,et al.  A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.

[153]  M. Kawada,et al.  Insulin-like Growth Factor I Secreted from Prostate Stromal Cells Mediates Tumor-Stromal Cell Interactions of Prostate Cancer , 2006 .

[154]  B. Tycko,et al.  Regulation of placental efficiency for nutrient transport by imprinted genes. , 2006, Placenta.

[155]  B. Hamel,et al.  Hypomethylation of the H19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype. , 2006, American journal of human genetics.

[156]  H. Okabe,et al.  Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma. , 2006, Human molecular genetics.

[157]  G. Kelsey,et al.  Imprinting the Gnas locus , 2006, Cytogenetic and Genome Research.

[158]  M. Parker,et al.  Nuclear receptor regulation gears up another Notch , 2006, Nuclear receptor signaling.

[159]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[160]  K. Jöckel,et al.  The GNAS1 T393C Polymorphism Predicts Survival in Patients with Clear Cell Renal Cell Carcinoma , 2006, Clinical Cancer Research.

[161]  Adam A. Margolin,et al.  PEG10 is a c-MYC target gene in cancer cells. , 2006, Cancer research.

[162]  E. Gelmann,et al.  Interaction of β-Catenin and TIF2/GRIP1 in Transcriptional Activation by the Androgen Receptor* , 2005, Journal of Biological Chemistry.

[163]  David I. Smith,et al.  Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines. , 2005, Gynecologic oncology.

[164]  J. Molès,et al.  The Candidate Tumor Suppressor Gene ZAC Is Involved in Keratinocyte Differentiation and Its Expression Is Lost in Basal Cell Carcinomas , 2005, Molecular Cancer Research.

[165]  H. Spencer,et al.  A census of mammalian imprinting. , 2005, Trends in genetics : TIG.

[166]  S. Sait,et al.  Alternative mechanisms associated with silencing of CDKN1C in Beckwith–Wiedemann syndrome , 2005, Journal of Medical Genetics.

[167]  K. Jöckel,et al.  GNAS1 T393C Polymorphism and Survival in Patients with Sporadic Colorectal Cancer , 2005, Clinical Cancer Research.

[168]  J. Golden,et al.  A Novel Variant of Inpp5f Is Imprinted in Brain, and Its Expression Is Correlated with Differential Methylation of an Internal CpG Island , 2005, Molecular and Cellular Biology.

[169]  J. Greer,et al.  Developmental abnormalities of neuronal structure and function in prenatal mice lacking the prader-willi syndrome gene necdin. , 2005, The American journal of pathology.

[170]  S. Horvath,et al.  Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.

[171]  F. Junyent,et al.  Zac1 is expressed in progenitor/stem cells of the neuroectoderm and mesoderm during embryogenesis: Differential phenotype of the Zac1‐expressing cells during development , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[172]  Joachim Diebold,et al.  Functional epigenomics identifies genes frequently silenced in prostate cancer. , 2005, Cancer research.

[173]  David A McCormick,et al.  Neuronal Networks: Flip-Flops in theBrain , 2005, Current Biology.

[174]  W. Schulz,et al.  Multiple mechanisms downregulate CDKN1C in human bladder cancer , 2005, International journal of cancer.

[175]  K. Jöckel,et al.  The T393C Polymorphism of the Gαs Gene (GNAS1) Is a Novel Prognostic Marker in Bladder Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[176]  W. Schulz,et al.  Effects of WNT/β-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines , 2005 .

[177]  D. Marchuk,et al.  Human Retroviral gag- and gag-pol-like Proteins Interact with the Transforming Growth Factor-β Receptor Activin Receptor-like Kinase 1*[boxs] , 2005, Journal of Biological Chemistry.

[178]  V. Baladrón,et al.  dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats. , 2005, Experimental cell research.

[179]  J. Svaren,et al.  A Loss of Insulin-like Growth Factor-2 Imprinting Is Modulated by CCCTC-binding Factor Down-regulation at Senescence in Human Epithelial Cells* , 2004, Journal of Biological Chemistry.

[180]  T. Hamilton,et al.  Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. , 2004, Gynecologic oncology.

[181]  S. Plymate,et al.  Androgen receptor (AR) expression in AR‐negative prostate cancer cells results in differential effects of DHT and IGF‐I on proliferation and AR activity between localized and metastatic tumors , 2004, The Prostate.

[182]  S. Varambally,et al.  JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence , 2004, Cancer Research.

[183]  Chawnshang Chang,et al.  Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells. , 2004, Molecular endocrinology.

[184]  F. van Coppenolle,et al.  Hormonal regulation of H19 gene expression in prostate epithelial cells. , 2004, The Journal of endocrinology.

[185]  R Engers,et al.  Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation , 2004, British Journal of Cancer.

[186]  Wolf Reik,et al.  Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops , 2004, Nature Genetics.

[187]  G. Kelsey,et al.  The imprinted signaling protein XLαs is required for postnatal adaptation to feeding , 2004, Nature Genetics.

[188]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[189]  D. French,et al.  Notch1-expressing Cells Are Indispensable for Prostatic Branching Morphogenesis during Development and Re-growth Following Castration and Androgen Replacement* , 2004, Journal of Biological Chemistry.

[190]  T. Jensen,et al.  Regulation of Human Skeletal Stem Cells Differentiation by Dlk1/Pref‐1 , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[191]  Min Chen,et al.  Tissue-specific imprinting of the G protein Gsalpha is associated with tissue-specific differences in histone methylation. , 2004, Human molecular genetics.

[192]  V. Pant,et al.  Mutation of a Single CTCF Target Site within the H19 Imprinting Control Region Leads to Loss of Igf2 Imprinting and Complex Patterns of De Novo Methylation upon Maternal Inheritance , 2004, Molecular and Cellular Biology.

[193]  K. Friedrich,et al.  Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck , 2004, Head & neck.

[194]  A. Feinberg,et al.  Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. , 2004, Gastroenterology.

[195]  Jeanne Kowalski,et al.  Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer , 2004, Cancer Research.

[196]  Jeong Hoon Kim,et al.  Synergistic effects of coactivators GRIP1 and beta-catenin on gene activation: cross-talk between androgen receptor and Wnt signaling pathways. , 2004, The Journal of biological chemistry.

[197]  K. Longo,et al.  Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues , 2003, Molecular Cancer.

[198]  Kristian Helin,et al.  EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer , 2003, The EMBO journal.

[199]  A. Tsou,et al.  Overexpression of a Novel Imprinted Gene, PEG10, in Human Hepatocellular Carcinoma and in Regenerating Mouse Livers , 2003, Journal of Biomedical Science.

[200]  S. Monti,et al.  Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. , 2003, Anticancer research.

[201]  J. Simons,et al.  Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[202]  Yusuke Nakamura,et al.  Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. , 2003, Cancer research.

[203]  J. Moul,et al.  Methylation of TFPI-2 gene is not the sole cause of its silencing. , 2003, International journal of oncology.

[204]  A. Hochberg,et al.  Inhibition of tumor growth by DT-A expressed under the control of IGF2 P3 and P4 promoter sequences. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[205]  A. Feinberg,et al.  Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk , 2003, Science.

[206]  Ling Lin,et al.  Highly Coordinated Gene Regulation in Mouse Skeletal Muscle Regeneration* 210 , 2003, The Journal of Biological Chemistry.

[207]  E. Gelmann,et al.  β-Catenin Binds to the Activation Function 2 Region of the Androgen Receptor and Modulates the Effects of the N-Terminal Domain and TIF2 on Ligand-Dependent Transcription , 2003, Molecular and Cellular Biology.

[208]  F. Holsboer,et al.  Transcriptional Activities of the Zinc Finger Protein Zac Are Differentially Controlled by DNA Binding , 2003, Molecular and Cellular Biology.

[209]  J. Shield,et al.  Transient neonatal diabetes, a disorder of imprinting , 2002, Journal of medical genetics.

[210]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[211]  S. Shenolikar,et al.  Targeting Protein Phosphatase 1 (PP1) to the Actin Cytoskeleton: the Neurabin I/PP1 Complex Regulates Cell Morphology , 2002, Molecular and Cellular Biology.

[212]  Mark D. Johnson,et al.  Peg3/Pw1 Is a Mediator between p53 and Bax in DNA Damage-induced Neuronal Death* , 2002, The Journal of Biological Chemistry.

[213]  A. Protopopov,et al.  The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. , 2002, Cancer research.

[214]  D. Givol,et al.  A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1 , 2002, Oncogene.

[215]  Yan Shi,et al.  Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells , 2001, Oncogene.

[216]  D. Feldman,et al.  The development of androgen-independent prostate cancer , 2001, Nature Reviews Cancer.

[217]  F. S. French,et al.  A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. , 2001, Cancer research.

[218]  H. Yoshioka,et al.  Epigenetic silencing of PEG3 gene expression in human glioma cell lines * , 2001, Molecular carcinogenesis.

[219]  A. Schönthal,et al.  Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1 , 2001, Oncogene.

[220]  J. Bockaert,et al.  Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities , 2001, Oncogene.

[221]  J. Ruijter,et al.  Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS. , 2001, Human molecular genetics.

[222]  T. Arzberger,et al.  The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas. , 2000, Cancer research.

[223]  C. Croce,et al.  Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[224]  Shih-Ming Huang,et al.  Mouse Zac1, a Transcriptional Coactivator and Repressor for Nuclear Receptors , 2000, Molecular and Cellular Biology.

[225]  D. Bowtell,et al.  Pw1/Peg3 is a potential cell death mediator and cooperates with Siah1a in p53-mediated apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[226]  R. Nicholls.  The impact of genomic imprinting for neurobehavioral and developmental disorders. , 2000, The Journal of clinical investigation.

[227]  D. Bonthron,et al.  The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes. , 2000, Human molecular genetics.

[228]  J. Swinnen,et al.  Androgens down-regulate the expression of the human homologue of Paternally expressed gene-3 in the prostatic adenocarcinoma cell line LNCaP , 1999, Molecular and Cellular Endocrinology.

[229]  T A Gray,et al.  An imprinted, mammalian bicistronic transcript encodes two independent proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[230]  E. Keverne,et al.  Regulation of maternal behavior and offspring growth by paternally expressed Peg3. , 1999, Science.

[231]  F. Apiou,et al.  hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[232]  D. Sassoon,et al.  Peg3/Pw1 is an imprinted gene involved in the TNF-NFκB signal transduction pathway , 1998, Nature Genetics.

[233]  K. Yoshikawa,et al.  Necdin, A Postmitotic Neuron-specific Growth Suppressor, Interacts with Viral Transforming Proteins and Cellular Transcription Factor E2F1* , 1998, The Journal of Biological Chemistry.

[234]  A. Godwin,et al.  Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells. , 1997, Cancer research.

[235]  J. Bockaert,et al.  Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain , 1997, The EMBO journal.

[236]  A. Godwin,et al.  Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumors , 1997, Oncogene.

[237]  L. Kunkel,et al.  Beyond dystrophin: current progress in the muscular dystrophies. , 1996, Current opinion in pediatrics.

[238]  S. Baylin,et al.  Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[239]  J. Thrasher,et al.  Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. , 1996, The Journal of clinical endocrinology and metabolism.

[240]  W. Isaacs,et al.  Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[241]  J. Brooks,et al.  Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[242]  F. S. French,et al.  Androgen and glucocorticoid receptors interact with insulin degrading enzyme. , 1994, The Journal of biological chemistry.

[243]  T. Moore,et al.  Genomic imprinting in mammalian development: a parental tug-of-war. , 1991, Trends in genetics : TIG.

[244]  C. Stewart,et al.  Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: Implications for genetic imprinting , 1990, Cell.

[245]  R. Heimer,et al.  Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. , 1990, The Journal of biological chemistry.

[246]  Hélène Jammes,et al.  Specific epigenetic alterations of IGF2-H19 locus in spermatozoa from infertile men , 2010, European Journal of Human Genetics.

[247]  Jahnvi Pflueger,et al.  Distinctive chromatin in human sperm packages genes for embryo development , 2009 .

[248]  M. Oshimura,et al.  Changes in expression of imprinted genes following treatment of human cancer cell lines with non-mutagenic or mutagenic carcinogens. , 2008, International journal of oncology.

[249]  P. Molloy,et al.  DNA hypomethylation and human diseases. , 2007, Biochimica et biophysica acta.

[250]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[251]  N. Kyprianou,et al.  Apoptosis evasion: The role of survival pathways in prostate cancer progression and therapeutic resistance , 2006, Journal of cellular biochemistry.

[252]  M. Ehrlich,et al.  Cancer-linked DNA hypomethylation and its relationship to hypermethylation. , 2006, Current topics in microbiology and immunology.

[253]  K. Mitsuya,et al.  Chromosome loops, insulators, and histone methylation: new insights into regulation of imprinting in clusters. , 2004, Cold Spring Harbor symposia on quantitative biology.

[254]  M. Oshimura,et al.  Coordinate downregulation of a novel imprinted transcript ITUP1 with PEG3 in glioma cell lines. , 2004, DNA research : an international journal for rapid publication of reports on genes and genomes.

[255]  K. Yoshikawa,et al.  Necdin interacts with the ribonucleoprotein hnRNP U in the nuclear matrix , 2002, Journal of cellular biochemistry.

[256]  J. S. Rao,et al.  Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro. , 2001, International journal of oncology.

[257]  G. Prendergast,et al.  Bau, a splice form of Neurabin-I that interacts with the tumor suppressor Bin1, inhibits malignant cell transformation. , 1999, Cell adhesion and communication.

[258]  Jie Liu,et al.  Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/en.2004-0865 Minireview: GNAS: Normal and Abnormal Functions , 2022 .

[259]  Nong Zhang,et al.  Bmc Molecular Biology Tissue Factor Pathway Inhibitor-2 Was Repressed by Cpg Hypermethylation through Inhibition of Klf6 Binding in Highly Invasive Breast Cancer Cells , 2022 .